Top

Clinical and Translational Oncology

Published in:

01-11-2012 | Research Article

Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC

Author: M. Grimm

Published in: Clinical and Translational Oncology | Issue 11/2012

Abstract

Background

Several clinicopathological parameters have been implicated in prognosis, recurrence and survival, following oral squamous cell carcinoma (OSCC). The purpose of this retrospective study was to review the outcome of patients with oral cavity squamous cell carcinoma treated at a single institution by primary surgical resection with or without adjuvant radiotherapy or radiochemotherapy, or brachytherapy and to identify the factors affecting survival and locoregional control.

Materials and methods

We retrospectively reviewed the records of 429 consecutive patients after primary radical R0 tumor resection and 55 patients after brachytherapy in our department between 1997 and 2010. OSCC pathological parameters were analyzed including age, gender, site distribution, tumor size, lymph node involvement, grading, microvascular invasion, lymphatic vessel involvement, and distant metastasis. Descriptive statistics were calculated for each variable and survival was calculated using the univariate Kaplan–Meier method. Prognostic factors were analyzed using the multivariate Cox proportional hazard model.

Results

Average tumor size was 10.9 mm (95 % CI for the mean 9.6–12.3). Disease-free survival at 5 years was 65 % and overall 5-year survival was 62 %. On univariate analysis, patients with increased tumor size, lymph node involvement, microvascular invasion, and lymphatic vessel involvement had a significant poor prognosis. Multivariate analysis showed that independent prognostic factors were increased tumor size and microvascular invasion.

Conclusion

This hospital-based retrospective cohort study points out different clinicopathological prognostic factors of survival in a large patient cohort treated for OSCC. It highlights increased tumor size and microvascular invasion as the most independent prognostic factors in predicting survival in patients with OSCC.

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952. doi:10.1056/NEJMoa032641350/19/1945 PubMedCrossRef

Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944. doi:10.1056/NEJMoa032646350/19/1937] PubMedCrossRef

Mazeron JJ, Crook JM, Benck V, Marinello G, Martin M, Raynal M, Haddad E, Peynegre R, Le Bourgeois JP, Walop W et al (1990) Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 19(6):1369–1376PubMedCrossRef

Lapeyre M, Hoffstetter S, Peiffert D, Guerif S, Maire F, Dolivet G, Toussaint B, Mundt A, Chassagne JF, Simon C, Bey P (2000) Postoperative brachytherapy alone for T1–2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 48(1):37–42. doi:S0360-3016(00)00538-1 PubMedCrossRef

Grandi C, Alloisio M, Moglia D, Podrecca S, Sala L, Salvatori P, Molinari R (1985) Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg 8(2):67–73PubMedCrossRef

Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97(6):1464–1470. doi:10.1002/cncr.11202 PubMedCrossRef

Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3–4):645–662. doi:10.1007/s10555-007-9082-y PubMedCrossRef

Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC (2007) Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories. Cancer 110(3):564–571. doi:10.1002/cncr.22814 PubMedCrossRef

Yoshizawa M, Shingaki S, Nakajima T, Saku T (1994) Histopathological study of lymphatic invasion in squamous cell carcinoma (O-1 N) with high potential of lymph node metastasis. Clin Exp Metastasis 12(6):347–356PubMedCrossRef

10.

Zhao D, Pan J, Li XQ, Wang XY, Tang C, Xuan M (2008) Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance. J Oral Pathol Med 37(10):616–625. doi:JOP70710.1111/j.1600-0714.2008.00707.x PubMedCrossRef

11.

Nakayama A, Ogawa A, Fukuta Y, Kudo K (1999) Relation between lymphatic vessel diameter and clinicopathologic parameters in squamous cell carcinomas of the oral region. Cancer 86(2):200–206. doi:10.1002/(SICI)1097-0142(19990715)86:2<200:AID-CNCR3>3.0.CO;2-# PubMedCrossRef

12.

Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 17(2):527–535. doi:10.1245/s10434-009-0755-3 PubMedCrossRef

13.

Jones HB, Sykes A, Bayman N, Sloan P, Swindell R, Patel M, Musgrove B (2009) The impact of lymphovascular invasion on survival in oral carcinoma. Oral Oncol 45(1):10–15. doi:10.1016/j.oraloncology.2008.03.009 PubMedCrossRef

14.

Niimi K, Yoshizawa M, Nakajima T, Saku T (2001) Vascular invasion in squamous cell carcinomas of human oral mucosa. Oral Oncol 37(4):357–364. doi:S1368-8375(00)00097-X PubMedCrossRef

15.

Close LG, Brown PM, Vuitch MF, Reisch J, Schaefer SD (1989) Microvascular invasion and survival in cancer of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 115(11):1304–1309PubMedCrossRef

16.

Maddox WA, Urist MM (1990) Histopathological prognostic factors of certain primary oral cavity cancers. Oncology (Williston Park) 4 (12):39–42; discussion 42, 45–36

17.

Kurokawa H, Yamashita Y, Murata T, Yoshikawa T, Tokudome S, Miura K, Kajiyama M (1998) Histological grading of malignancy correlates with regional lymph node metastasis and survival of patients with oral squamous cell carcinoma. Fukuoka Igaku Zasshi 89(8):225–231PubMed

18.

Larsen SR, Johansen J, Sorensen JA, Krogdahl A (2009) The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 38(8):657–662. doi:10.1111/j.1600-0714.2009.00797.x PubMedCrossRef

19.

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167–178. doi:00000478-200502000-00003 PubMedCrossRef

20.

Kurita H, Koike T, Narikawa JN, Sakai H, Nakatsuka A, Uehara S, Kobayashi H, Kurashina K (2004) Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol 40(9):898–903. doi:10.1016/j.oraloncology.2004.04.004 PubMedCrossRef

21.

Sobin LH, Wittekind Ch (2002) UICC. TNM Classification of malignant tumors, 6th edn. Springer, Berlin

22.

Hamilton SR, Aaltonen LA (2000) Pathology and genetics. Tumours of the digestive system, 3rd edn. IARC Press, Lyon

23.

Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 75:457–487CrossRef

24.

Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170PubMed

25.

Cox DR (1972) Regression models and life tables. J Roy Stat Soc 34:1987–2001

26.

Mucke T, Wagenpfeil S, Kesting MR, Holzle F, Wolff KD (2009) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45(8):687–691. doi:10.1016/j.oraloncology.2008.10.011 PubMedCrossRef

27.

Liu SA, Wong YK, Lin JC, Poon CK, Tung KC, Tsai WC (2007) Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg 136(1):112–118. doi:10.1016/j.otohns.2006.07.002 PubMedCrossRef

28.

Bagan JV, Scully C (2008) Recent advances in oral oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol 44(2):103–108. doi:S1368-8375(08)00009-2 PubMedCrossRef

29.

Jones AS, Beasley N, Houghton D, Husband DJ (1998) The effects of age on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin Otolaryngol Allied Sci 23(1):51–56PubMedCrossRef

30.

Carinci F, Pelucchi S, Farina A, Bonsetti G, Mastrandrea M, Calearo C (1997) Site-dependent survival in cancer of the oral cavity. J Craniofac Surg 8(5):399–403 (discussion 404)PubMedCrossRef

31.

Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C (2010) Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1–T2 oral squamous cell carcinoma patients. Head Neck Oncol 2:9. doi:1758-3284-2-910.1186/1758-3284-2-9 PubMedCrossRef

32.

Favia G, Maiorano E, Capodiferro S, Pilolli GP, Lacaita MG, Lajolo C, Giuliani M, Martinelli D, Germinario C (2008) Oral squamous cell carcinoma: a mono-institutional epidemiological study on 462 cases highlighting differences among young and adult patients. Minerva Stomatol 57(9):413–421PubMed

33.

Skitarelic N, Morovic M, Manestar D (2007) Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Craniomaxillofac Surg 35(1):15–20. doi:S1010-5182(07)00005-4 PubMedCrossRef

34.

Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, Singh B, Wong RJ, Patel SG (2009) Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 115(24):5700–5710. doi:10.1002/cncr.24631 PubMedCrossRef

35.

Barnes L, Everson J, Reichart P, Sidransky D (2005) World Health Organization classification of tumours: pathology and genetics of head and neck tumors. IARC Press, Lyon, pp 168–174

36.

Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52(4):195–215PubMedCrossRef

37.

Papageorge MB (2007) Etiology of oral cancer in the young patient: is tongue cancer becoming the other cancer in women? Oral Maxillofac Surg Clin North Am 19 (2):163–171. doi:10.1016/j.coms.2007.01.004

38.

Effiom OA, Adeyemo WL, Omitola OG, Ajayi OF, Emmanuel MM, Gbotolorun OM (2008) Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria. J Oral Maxillofac Surg 66(8):1595–1599. doi:10.1016/j.joms.2007.12.025 PubMedCrossRef

39.

Walker D, Boey G, McDonald L (2003) The pathology of oral cancer. Pathology 35:376–383PubMedCrossRef

40.

Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21(3):194–200. doi:10.1097/CCO.0b013e32832a68ca PubMedCrossRef

41.

Lin CS, Jen YM, Cheng MF, Lin YS, Su WF, Hwang JM, Chang LP, Chao HL, Liu DW, Lin HY, Shum WY (2006) Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck 28(2):150–157. doi:10.1002/hed.20303 PubMedCrossRef

42.

Wong RJ, Keel SB, Glynn RJ, Varvares MA (2000) Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope 110(1):65–72. doi:10.1097/00005537-200001000-00013 PubMedCrossRef

43.

Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104(3):336–344. doi:10.1002/ijc.10960 PubMedCrossRef

44.

Schiefke F, Hildebrandt G, Pohlmann S, Heinicke F, Hemprich A, Frerich B (2008) Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg 36(5):285–292. doi:10.1016/j.jcms.2007.08.009 PubMedCrossRef

45.

Do L, Puthawala A, Syed N (2009) Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 8(4):385–391. doi:10.1016/j.brachy.2009.03.191 PubMedCrossRef

46.

Severino P, Alvares AM, Michaluart P Jr, Okamoto OK, Nunes FD, Moreira-Filho CA, Tajara EH (2008) Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes 1:113. doi:10.1186/1756-0500-1-113 PubMedCrossRef

Title: Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC
Author: M. Grimm
Publication date: 01-11-2012
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 11/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-012-0867-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2012

Practical guidelines for dose individualization of anticancer targeted drugs

Primary pineal tumors: outcome and prognostic factors—a study from the Rare Cancer Network (RCN)

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer

miRNAs as biomarkers in prostate cancer

Clinical implications of the ENCODE project

Keynote webinar | Spotlight on antibody–drug conjugates in cancer